[HTML][HTML] Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer …
Background Weighing risks and benefits is currently the primary criterion for decisions
regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the …
regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the …
[PDF][PDF] Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer …
K Ribi, N Kalbermatten2y, M Eicher, F Strasser - academia.edu
Background: Weighing risks and benefits is currently the primary criterion for decisions
regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the …
regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the …
[HTML][HTML] Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer …
K Ribi, N Kalbermatten, M Eicher, F Strasser - ESMO Open, 2022 - esmoopen.com
Background Weighing risks and benefits is currently the primary criterion for decisions
regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the …
regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the …
[HTML][HTML] Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer …
K Ribi, N Kalbermatten, M Eicher, F Strasser - ESMO Open, 2022 - ncbi.nlm.nih.gov
Background Weighing risks and benefits is currently the primary criterion for decisions
regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the …
regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the …
Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer …
K Ribi, N Kalbermatten, M Eicher… - ESMO open, 2022 - pubmed.ncbi.nlm.nih.gov
Background Weighing risks and benefits is currently the primary criterion for decisions
regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the …
regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the …
Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer …
K Ribi, N Kalbermatten, M Eicher, F Strasser - ESMO Open, 2022 - europepmc.org
Background Weighing risks and benefits is currently the primary criterion for decisions
regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the …
regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the …